Cover Image

Relevansi Konsep Viral Sovereignty dalam Penanganan Pandemi COVID-19 di Indonesia



Ikhlas Tawazun(1*), Brianna Ruth Audrey(2)

(1) University of Indonesia
(2) Hubungan Internasional Universitas Indonesia
(*) Corresponding Author

Abstract


Menurut Menteri Kesehatan Siti Fadilah Supari di Kabinet Indonesia Bersatu (2004-2009), Indonesia memiliki hak untuk tidak membagikan sampel virus yang terdapat di dalam wilayahnya kepada siapapun. Argumen itu diartikulasikan ketika wabah H5N1 sedang mencapai puncaknya. Meski tidak disebutkan secara eksplisit, argumen tersebut sering dimengerti sebagai viral sovereignty. Argumen ini diutarakan sehubungan dengan kritik terhadap international health regime dan ketidakadilan dalam akses terhadap pengembangan dan pemerolehan vaksin semasa wabah H5N1. Kini, dunia, tidak terkecuali Indonesia, kembali dilanda wabah yang lebih besar: COVID-19. Wabah COVID-19 yang telah mencapai taraf pandemi ini tentu kembali mengangkat keberadaan konsep viral sovereignty. Oleh karena itu, artikel ini didasarkan pada pertanyaan, “Apakah penerapan konsep viral sovereignty relevan dalam penanganan pandemi COVID-19 di Indonesia?”. Tulisan ini didasarkan oleh argumen yang menyatakan bahwa masih terdapat relevansi yang signifikan dari konsep viral sovereignty dalam penanganan pandemi COVID-19 di Indonesia.


Keywords


Viral Sovereignty; International Health Regime; Indonesia; H5N1; COVID-19

Full Text:

PDF


References

Andanda, Pamela, Sachin Chaturvedi, Emezat Mengesha, dan Tim Hodges. “Legal Frameworks for Benefit Sharing: From Biodiversity to Human Genomics.” Benefit Sharing: From Biodiversity to Human Genetics. Diedit oleh Doris Schroeder. London: Springer International Publishing, 2013.

Andriyanto, Heru. “Indonesian Defense Industries to Produce Ventilators.” Jakarta Globe. 16 April 2020, dari https://jakartaglobe.id/tech/indonesian-defense-industries-to-produce-ventilators

Arnason, Gardar. “Exploring Central Philosophical Concepts in Benefit Sharing: Vulnerability, Exploitation and Undue Inducement.” Benefit Sharing: From Biodiversity to Human Genetics. Diedit oleh Doris Schroeder. London: Springer International Publishing , 2013.

Bauomy, Jasmin. “Once a COVID-19 Vaccine Is Found, What Happens next?” euronews, Agustus 1, 2020. https://www.euronews.com/2020/08/01/once-a-covid-19-vaccine-is-found-what-happens-next. (diakses pada 11 Agustus, 2020)

BBC. “Coronavirus confirmed as pandemic by World Health Organization.” 11 Maret 2020, https://www.bbc.com/news/world-51839944 (diakses 10 Agustus 2020)

Britannica. “World Health Organization” diakses 10 Agustus 2020, dari https://www.britannica.com/topic/World-Health-Organization

Caplan, Arthur L., dan David R. Curry. “Leveraging Genetic Resources or Moral Blackmail? Indonesia and Avian Flu Virus Sample Sharing.” The American Journal of Bioethics 7, no. 11 (15 November, 2007): 1–2. https://doi.org/10.1080/15265160701728958.

Center for Disease Control and Prevention, “Highly Pathogenic Asian Avian Influenza A(H5N1) Virus” CDC. 12 Desember 2018, https://www.cdc.gov/flu/avianflu/h5n1-virus.htm#:~:text=The%20virus%20was%20first%20detected,Europe%2C%20and%20the%20Middle%20East. (diakses pada 19 Juli 2020)

Chung, Emily. “Some Countries May Get Faster Access to a COVID-19 Vaccine than Others. Here’s Why | CBC News.” CBCnews. Agustus 2, 2020, https://www.cbc.ca/news/health/covid-19-vaccine-countries-world-1.5668835. (diakses pada 11 Agustus 2020)

CNN Indonesia. “Menristek: Butuh Riset Agar Rapid Test Covid-19 Tidak Impor” 13 Juli 2020, https://www.cnnindonesia.com/teknologi/20200710162951-199-523322/menristek-butuh-riset-agar-rapid-test-covid-19-tidak-impor (diakses pada 21 Juli 2020)

Detik, “WHO Izinkan Tamiflu Made in Indonesia” Detik. 26 November, 2005, https://news.detik.com/berita/d-486941/who-izinkan-tamiflu-made-in-indonesia (diakses pada 19 Juli 2020)

DW, “Indonesia Dukung Resolusi WHA, Tak Sebut Investigasi Asal Corona” 20 Mei 2020, https://www.dw.com/id/indonesia-dukung-resolusi-wha-tak-sebut-investigasi-asal-corona/a-53511448 (diakses pada 10 Agustus 2020)

Elbe, Stefan. The Handbook of Global Health Policy, diedit oleh Nadine Voelkner, 305–16. Oxford, UK: John Wiley & Sons, 2014.

GAVI. COVID-19 Vaccine Global Access (COVAX) Facility Preliminary Technical Design. Geneva: GAVI, 2020.

GAVI. “More than 150 Countries Engaged in COVID-19 Vaccine Global Access Facility.” GAVI. 15 Juli, 2020, https://www.gavi.org/news/media-room/more-150-countries-engaged-covid-19-vaccine-global-access-facility. (diakses pada 11 Agustus 2020)

GAVI. “What Is the COVAX Pillar, Why Do We Need It and How Will It Work?” #VaccinesWork. GAVI. 26 Juni, 2020, https://www.gavi.org/vaccineswork/gavi-ceo-dr-seth-berkley-explains-covax-pillar. (diakses pada 11 Agustus 2020)

Hancock, Jay. “They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma.” Kaiser Health News, August 26, 2020. https://khn.org/news/rather-than-give-away-its-covid-vaccine-oxford-makes-a-deal-with-drugmaker/.

Helfer, Lawrence R. “Regime Shifting in the International Intellectual Property System,” Perspectives on Politics 7, No. 1 (2009): 39–44.

Lucas, Julie Cook, Gardar Arnason, Pamela Andanda, Joshua Kimani, Veronique Fournier, dan Meena Krishnamuurthy. “Donating Human Samples: Who Benefits? Cases from Iceland, Kenya and Indonesia.”dalam Benefit Sharing: From Biodiversity to Human Genetics, diedit oleh Doris Schroeder, 95–127. London: Springer International Publishing , 2013.

Lynch, Colum. “‘America First’ vs. ‘The People’s Vaccine’” Foreign Policy. 6 Juli, 2020, https://foreignpolicy.com/2020/07/06/coronavirus-vaccine-nationalism-america-first-covax/. (diakses pada 11 Agustus 2020)

Mahoney, James dan Kathleen Thelen. “A Theory of Gradual Institutional Change,” Explaining Institutional Change: Ambiguity, Agency, and Power, ed. James Mahoney dan Kathleen Thelen. Cambridge: Cambridge University Press, 2010.

McKeever, Amy. “Here’s What We’ll Lose If the U.S. Cuts Ties with the WHO,” July 10, 2020. https://www.nationalgeographic.com/science/2020/07/what-we-will-lose-if-united-states-cuts-ties-with-world-health-organization/.

Nickelsburg, Monica. “Ventec and GM, 2 months later: How a startup took on the ventilator shortage, and where it stands now”Geekwire. 2 June 2020, dari https://www.geekwire.com/2020/ventec-gm-2-months-later-startup-took-ventilator-shortage-stdans-now/ (diakses pada 21 Juli 2020)

Novika, Soraya. “Kenapa RI Doyan Impor Ventilator?”. Detik. 23 Juni 2020, dari https://finance.detik.com/industri/d-5065203/kenapa-ri-doyan-impor-ventilator (diakses pada 21 Juli 2020)

Our World in Data, “Cumulative COVID-19 Tests per 1.000 people” diakses 23 Oktober, dari https://ourworldindata.org/coronavirus-data-explorer?zoomToSelection=true&country=USA~IDN&region=World&testsMetric=true&interval=total&perCapita=true&smoothing=0&pickerMetric=location&pickerSort=asc

Our World in Data, “Cumulative COVID-19 Tests” diakses 23 Oktober 2020, dari https://ourworldindata.org/coronavirus-data-explorer?zoomToSelection=true&country=USA~IDN&region=World&testsMetric=true&interval=total&smoothing=0&pickerMetric=location&pickerSort=asc

Our World in Data. “Cumulative COVID-19 Tests per 1000 people.” diakses pada 10 Agustus 2020, dari https://ourworldindata.org/coronavirus-data-explorer?zoomToSelection=true&testsMetric=true&interval=total&hideControls=true&perCapita=true&smoothing=0&country=IDN~OWID_WRL~USA&pickerMetric=location&pickerSort=asc

Our World in Data, “Daily New COVID-19 Tests” diakses 23 Oktober 2020, dari https://ourworldindata.org/coronavirus-data-explorer?zoomToSelection=true&country=USA~IDN&region=World&testsMetric=true&interval=daily&smoothing=0&pickerMetric=location&pickerSort=asc

Rabitz, Florian. The Global Governance of Genetic Resources: Institutional Change and Structural Constraints. Abingdon, Oxon: Routledge, Taylor & Francis, 2017.

Rauhala, Emily, and Yasmeen Abutaleb. “U.S. Says It Won’t Join WHO-Linked Effort to Develop, Distribute Coronavirus Vaccine.” The Washington Post. WP Company, September 2, 2020. https://www.washingtonpost.com/world/coronavirus-vaccine-trump/2020/09/01/b44b42be-e965-11ea-bf44-0d31c85838a5_story.html.

Raustiala, Kal dan David G. Victor. “The Regime Complex for Plant Genetic Resources,” International Organization 58, No. 2 (2004): 300-305.

Rourke, Michael, Mark Eccleston-Turner, Alexandra Phelan, dan Lawrence Gostin. “Policy Opportunities to Enhance Sharing for pandemic Research.” Science Magazine 368, No. 6942, (2020): 716-718.

Sedyaningsih, Endang R., Siti Isfandari, Triono Soendoro, dan Siti F. Supari. “Towards Mutual Trust, Transparency and Equity in Virus Sharing Mechanism: The Avian Influenza Case of Indonesia.” Annals of the Academy of Medicine Singapore 37, No. 6 (2008): 482–88.

Shu, Yuelong, dan John Mccauley. “GISAID: Global Initiative on Sharing All Influenza Data – from Vision to Reality.” Eurosurveillance 22, no. 13 (30 Maret, 2017): 1–3. https://doi.org/10.2807/1560-7917.es.2017.22.13.30494.

Syakriah, Ardila. “Eijkman Institute Finishes Sequencing Indonesian Coronavirus Strain.” The Jakarta Post. 4 Mei, 2020. https://www.thejakartapost.com/news/2020/05/04/eijkman-institute-finishes-sequencing-indonesian-coronavirus-strain.html. (diakses pada 19 Juli 2020).

United Nations. Convention on Biological Diversity. Rio de Janeiro, Brazil: United Nations, 1992.

United Nations Environment Programme. Nagoya Protocol. Montreal, Canada: Secretariat of the Convention on Biological Diversity, 2011.

United States Food and Drug Administration, “H5N1 Influenza Virus Vaccine, manufactured by Sanofi Pasteur, Inc. Questions and Answers” US FDA. 23 Maret 2018, https://www.fda.gov/vaccines-blood-biologics/vaccines/h5n1-influenza-virus-vaccine-manufactured-sanofi-pasteur-inc-questions-and-answers (diakses pada 19 Juli 2020).

World Health Organization. COVAX, the ACT-Accelerator Vaccines Pillar. Geneva: WHO Team, 2020.

World Health Organization. “Human Animal Interface” WHO. https://www.who.int/influenza/human_animal_interface/2020_01_20_tableH5N1.pdf?ua=1 (diakses pada 19 Juli 2020)

World Health Organization. Implementation of the Nagoya Protocol in the Context of Human and Animal Health, and Food Safety: Access to Pathogens and Fair and Equitable Sharing of Benefits. Geneva: Secretariat of the Convention on Biological Diversity and World Health Organization, 2018.

World Health Organization. International Health Regulations. 2nd ed. Geneva, Switzerland: WHO Press, 2005.

World Health Organization .“Novel Coronavirus - China” 12 Januari 2020. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ (diakses 10 Agustus 2020)

World Health Organization. Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits. Geneva: WHO, 2011.

World Health Organization, “WHO Launches New Global Influenza Strategy” WHO. 11 March 2019, https://www.who.int/news-room/detail/11-03-2019-who-launches-new-global-influenza-strategy (diakses pada 10 Juni 2020)

World Intellectual Property Organization, “Avian Flu Drugs: Patent Questions” WIPO Magazine. April 2006, https://www.wipo.int/wipo_magazine/en/2006/02/article_0005.html
Young, Oran R. “Regime dynamics: the rise and fall of international regimes.” International Organization 36, No. 2, International Regimes (Spring, 1982): 277-297.




Article Metrics

Abstract views : 716 | views : 489

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Diterbitkan oleh BPPM Balairung, Universitas Gadjah Mada
Kompleks Perumahan Dosen UGM, Bulaksumur B-21, Caturtunggal, Kecamatan Depok, Kabupaten Sleman, Yogyakarta 55281.
email: balairungpress@gmail.com | LINE: @GSJ9240C | http://balairungpress.com
    
2018 BPPM BALAIRUNG UGM